NEULANDLABBSENeuland Laboratories LtdHighPositive
Announced Tue, 12 May · 18:02 IST

Recommendation of final dividend for the financial year 2025-26

Dividend Yield Above 3pctCorporate Actions View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹17100.00
prior close
₹18305.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.3-4.7-4.7-4.3-2.5-3.5-4.7-2.7-2.7-2.5-1.2-0.2+11.0
Up moveDown movePending
AI summary

Neuland Laboratories has recommended a final dividend of Rs. 34 per equity share (340% on face value of Rs. 10) for FY 2025-26, subject to shareholder approval at the 42nd AGM on August 4, 2026. The record date for determining eligible shareholders is July 24, 2026. The company reported strong financial performance with consolidated revenue of Rs. 2,02,299 lakhs, up 37% from Rs. 1,47,684 lakhs in the previous year. Profit after tax stood at Rs. 36,400 lakhs with EPS of Rs. 283.71. Additionally, the board approved a capacity expansion of 120.5 KL at Unit 1 in Telangana with an investment of Rs. 143.4 crores over 12-18 months, to be funded through internal accruals and borrowings.

Likely market impact

The recommended dividend reflects the company's strong cash generation and profitability. Combined with capacity expansion plans, this indicates healthy fundamentals and growth orientation, which could positively influence investor sentiment.